U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drug Shortages

FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Ketorolac Tromethamine Injection
Status: Currently in Shortage
»Date first posted: 03/23/2018
»Therapeutic Categories: Analgesia/Addiction

Expand all

Alembic Pharmaceuticals (Reverified 07/17/2024)

Company Contact Information:
908-393-9604

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Injection, 15 mg/1 mL (NDC 62332-599-25) Available
Injection, 30 mg/1 mL (NDC 62332-600-25) Available
Injection, 60 mg/2 mL (NDC 62332-601-25) Available

Baxter Healthcare (Revised 07/17/2024)

Company Contact Information:
888-229-0001

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 0338-0069-10) Limited Availability Recovery August 2024 Demand increase for the drug
Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0338-0072-25) Available FOR INTRAVENOUS AND INTRAMUSCULAR USE. 30mg/mL (1 mL fill volume/ 2 mL container)

Fresenius Kabi USA, LLC (Reverified 07/16/2024)

Company Contact Information:
888-386-1300

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Injection, 15 mg/1 mL (NDC 76045-107-10) Unavailable Not available at this time. Other
Injection, 30 mg/1 mL (NDC 76045-104-10) Unavailable Not available at this time. Other
Injection, 60 mg/2 mL (NDC 76045-105-20) Available Check wholesaler inventory
Injection, 15 mg/1 mL (NDC 63323-161-01) Available Check wholesaler inventory
Injection, 30 mg/1 mL (NDC 63323-162-01) Available Check wholesaler inventory
Injection, 30 mg/1 mL (NDC 63323-162-02) Available Check wholesaler inventory

Gland Pharma Limited (Revised 07/15/2024)

Company Contact Information:
855-273-0154

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 70860-700-01) Available
Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 70860-701-01) Available
Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 70860-701-02) Available
Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 70860-701-03) Available
Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 70860-700-02) Available
Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 70860-701-04) Available
Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 72266-118-25) Available
Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 72266-119-25) Available

Hikma Pharmaceuticals USA, Inc. (Revised 05/17/2024)

Company Contact Information:
800-631-2174

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Injection, 15 mg/1 mL (NDC 0641-6041-25) Unavailable Shortage recovery: TBD Other
Injection, 30 mg/1 mL (NDC 0641-6042-25) Unavailable Shortage recovery: TBD Other
Injection, 30 mg/1 mL (NDC 0641-6043-25) Unavailable Shortage recovery: TBD Other

Hospira, Inc., a Pfizer Company (Revised 07/15/2024)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Injection, 15 mg/1 mL (NDC 0409-3793-01) Available
Injection, 30 mg/1 mL (NDC 0409-3795-01) Available
Injection, 60 mg/2 mL (30 mg/mL) (NDC 0409-3796-01) Available

Sagent Pharmaceuticals (Reverified 07/01/2024)

Company Contact Information:
866-625-1618

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Injection, 15 mg/1 mL (NDC 25021-700-01) Available
Injection, 30 mg/1 mL (NDC 25021-701-02) Available
Injection, 30 mg/1 mL (NDC 25021-701-01) Available
Back to Top